DUBLIN–(BUSINESS WIRE)–The “Cancer
Vaccines Market: Global Industry Analysis, Trends, Market Size and
Forecasts up to 2024” report has been added to ResearchAndMarkets.com’s
The report predicts the global cancer vaccines market to grow with a
CAGR of 17.8 % over the period of 2018 – 2024
The report on cancer vaccines market is a comprehensive study and
presentation of drivers, restraints, opportunities, demand factors,
market size, forecasts, and trends in the global cancer vaccines market
over the period of 2016 to 2024. Moreover, the report is collective
presentation of primary and secondary research findings.
Porter’s five forces model in the report provides insights into the
competitive rivalry, supplier and buyer positions in the market and
opportunities for the new entrants in the global cancer vaccines market
over the period of 2016 – 2024. Further, the author’s Growth Matrix
given in the report brings an insight on the investment areas that
existing or new market players can consider.
The global cancer vaccines market is segmented on the basis of
technology, type, indication, and end user.
Global Cancer Vaccines Market by Technology
- Whole Cell Cancer Vaccine
- Dendritic Cells Cancer Vaccines
- Antigen/Adjuvant Cancer Vaccines
- Recombinant Cancer Vaccines
- Viral Vector & DNA Cancer Vaccines
Global Cancer Vaccines Market by Type
- Preventive Cancer Vaccines
- Therapeutic Cancer Vaccines
Global Cancer Vaccines Market by Indication
- Prostate Cancer
- Cervical Cancer
Global Cancer Vaccines Market by End User
- Adult Vaccines
- Pediatric Vaccine
Global Cancer Vaccines Market by Regions
- North America
- Glaxosmithkline Plc
- Aduro BioTech Inc.
- Astellas Pharma Inc.
- Merck & Co., Inc.
- CSL Limited
- Sanpower Group
- Sanofi Pasteur
- Pfizer Inc
- Serum Institute of India Pvt. Ltd.
For more information about this report visit https://www.researchandmarkets.com/research/c52v23/cancer_vaccines?w=4
Laura Wood, Senior Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900